Choi IS - Search Results

1

Genomic and transcriptomic profiles associated with response to eribulin and nivolumab combination in HER-2-negative metastatic breast cancer.

Park C, Suh KJ, Kim SH, Lee KH, Im SA, Kim MH, Sohn J, Jeong JH, Jung KH, Lee KE, Park YH, Kim HJ, Cho EK, Choi IS, Noh SJ, Shin I, Cho DY, Kim JH. Park C, et al. Among authors: choi is. Cancer Immunol Immunother. 2024 Aug 6;73(10):197. doi: 10.1007/s00262-024-03782-7. Cancer Immunol Immunother. 2024. PMID: 39105849 Free PMC article. Clinical Trial.

2

Efficacy of modified regimen with attenuated doses of paclitaxel plus carboplatin combination chemotherapy in elderly and/or weak patients with advanced non-small cell lung cancer.

Choi IS, Kim BS, Park SR, Lee SY, Kim DY, Kim JH, Lee SH, Kim TY, Heo DS, Bang YJ, Kim NK. Choi IS, et al. Lung Cancer. 2003 Jan;39(1):99-101. doi: 10.1016/s0169-5002(02)00389-6. Lung Cancer. 2003. PMID: 12499101 Clinical Trial.

3

Treatment outcome of adult acute lymphocytic leukemia with VPD(L) regimen: analysis of prognostic factors.

Park SR, Kim JH, Kim DY, Lee S, Lee SY, Choi IS, Yoon SS, Park S, Kim BG, Kim NK. Park SR, et al. Among authors: choi is. Korean J Intern Med. 2003 Mar;18(1):21-8. doi: 10.3904/kjim.2003.18.1.21. Korean J Intern Med. 2003. PMID: 12760264 Free PMC article.

4

Paclitaxel/Platinum-based perioperative chemotherapy and surgery in stage IIIA non-small cell lung cancer.

Choi IS, Oh DY, Kwon JH, Kim SI, Park SR, Bak JY, Kim JH, Kim DW, Kim YT, Kim TY, You CK, Kim YW, Heo DS, Bang YJ, Sung SW, Park CI, Kim NK. Choi IS, et al. Jpn J Clin Oncol. 2005 Jan;35(1):6-12. doi: 10.1093/jjco/hyi008. Jpn J Clin Oncol. 2005. PMID: 15681597

5

Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib.

Han SW, Kim TY, Hwang PG, Jeong S, Kim J, Choi IS, Oh DY, Kim JH, Kim DW, Chung DH, Im SA, Kim YT, Lee JS, Heo DS, Bang YJ, Kim NK. Han SW, et al. Among authors: choi is. J Clin Oncol. 2005 Apr 10;23(11):2493-501. doi: 10.1200/JCO.2005.01.388. Epub 2005 Feb 14. J Clin Oncol. 2005. PMID: 15710947 Clinical Trial.

6

Reduced dose intensity FOLFOX-4 as first line palliative chemotherapy in elderly patients with advanced colorectal cancer.

Kim JH, Oh DY, Kim YJ, Han SW, Choi IS, Kim DW, Im SA, Kim TY, Lee JS, Heo DS, Bang YJ, Kim NK. Kim JH, et al. Among authors: choi is. J Korean Med Sci. 2005 Oct;20(5):806-10. doi: 10.3346/jkms.2005.20.5.806. J Korean Med Sci. 2005. PMID: 16224154 Free PMC article.

7

Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer.

Lee KW, Im SA, Yun T, Song EK, Na Ii, Shin H, Choi IS, Oh DY, Kim JH, Kim DW, Kim TY, Lee JS, Heo DS, Bang YJ, Kim NK. Lee KW, et al. Among authors: choi is. Jpn J Clin Oncol. 2005 Dec;35(12):720-6. doi: 10.1093/jjco/hyi198. Epub 2005 Dec 6. Jpn J Clin Oncol. 2005. PMID: 16332718 Clinical Trial.

8

Phase II study of low-dose paclitaxel and cisplatin as a second-line therapy after 5-fluorouracil/platinum chemotherapy in gastric cancer.

Lee KW, Kim JH, Yun T, Song EK, Na II, Shin H, Oh SY, Choi IS, Oh DY, Kim DW, Im SA, Kim TY, Lee JS, Heo DS, Bang YJ, Kim NK. Lee KW, et al. Among authors: choi is. J Korean Med Sci. 2007 Sep;22 Suppl(Suppl):S115-21. doi: 10.3346/jkms.2007.22.S.S115. J Korean Med Sci. 2007. PMID: 17923737 Free PMC article. Clinical Trial.

9

Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement.

Lee KW, Yi J, Choi IS, Kim JH, Bang SM, Kim DW, Im SA, Kim TY, Yoon SS, Lee JS, Bang YJ, Park S, Kim BK, Cho HI, Heo DS. Lee KW, et al. Among authors: choi is. Ann Hematol. 2009 Sep;88(9):829-38. doi: 10.1007/s00277-008-0682-6. Epub 2009 Jan 27. Ann Hematol. 2009. PMID: 19172274

10

A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer.

Oh DY, Cha Y, Choi IS, Yoon SY, Choi IK, Kim JH, Oh SC, Kim CD, Kim JS, Bang YJ, Kim YH. Oh DY, et al. Among authors: choi is, choi ik. Cancer Chemother Pharmacol. 2010 Feb;65(3):527-36. doi: 10.1007/s00280-009-1059-9. Epub 2009 Jul 4. Cancer Chemother Pharmacol. 2010. PMID: 19578850 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,176 results

Search Page

Filters